col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


14 Results       Page 1

 [1] 
Wiley: Basic & Clinical Pharmacology & Toxicology
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―12 Matrix metalloproteinases are associated with severity of disease among COVID-19 patients: A possible pharmacological target Gisele Lopes Cavalcante, Lívia Pimenta Bonifacio, Jéssica Maria Sanches-lopes, Fernanda Guioti Puga, Felipe Santos de Carvalho, Fernando Bellissimo-Rodrigues, Jose Eduardo Tanus-Santos
2 [GO] 2023―Oct―31 Trends in medication use at the onset of and during the COVID-19 pandemic in the Republic of Ireland: an interrupted time series study Molly Mattsson, Jung Ah. Hong, John Scott Frazer, Glenn Ross Frazer, Frank Moriarty
3 [GO] 2023―Apr―11 Vitamin D and SARS-CoV-2 Sofie-Louise Feentved Ødum, Martin Kongsbak-Wismann
4 [GO] 2022―Sep―27 GABA A receptors as targets for anaesthetics and analgesics and promising candidates to help treat coronavirus infections: a mini-review Yujia Luo, Thomas Balle
5 [GO] 2022―Jun―21 Initiation of antihypertensive drugs to patients with confirmed COVID-19 - a population-based cohort study in Sweden Salar Issa Mousa, Fredrik Nyberg, Mohammadhossein Hajiebrahimi, Rebecka Bertilsson, Jonatan Nåtman, Ailiana Santosa, Björn Wettermark
6 [GO] 2021―Nov―23 Home pharmacological therapy in early COVID-19 to prevent hospitalization and reduce mortality. Time for a suitable proposal Sergio Pandolfi, Salvatore Chirumbolo, Giovanni Ricevuti, Luigi Valdenassi, Geir Bjørklund, Roman Lysiuk, et al. (+3)
7 [GO] 2021―Oct―27 Transfer of chemicals to a secondary container, from the introduction of new labelling regulation to COVID-19 lockdown: a retrospective analysis of exposure calls to the Poison Control Centre of Rome, Italy, 2017-2020 Michele Stanislaw Milella, Maria Caterina Grassi, Alessia Gasbarri, Valeria Mezzanotte, Francesco Pugliese, Gabriella Vivino
8 [GO] 2021―Sep―08 Home therapy of COVID-19 at the earliest may greatly prevent hospitalization Sergio Pandolfi, Salvatore Chirumbolo
9 [GO] 2021―May―12 An update on emerging therapeutics to combat COVID-19 Naveed Nazir Shah, Showkat Ul Nabi, Showkeen Muzamil Bashir, Muzafar Ahmad Rather, Qudratullah Kalwar, Sofi Imtiyaz Ali, et al. (+2)
10 [GO] 2021―Feb―06 Choppy Waters: The Importance of Accounting for Shifting Drug Utilization During the COVID-19 Pandemic in Future Observational Drug-related Studies Ahmad Shakeri, Tara Gomes, Katie Suda, Mina Tadrous
11 [GO] 2020―Nov―25 The tyrosine kinase inhibitor nilotinib inhibits SARS-CoV-2 In Vitro Valeria Cagno, Gaelle Magliocco, Caroline Tapparel, Youssef Daali
12 [GO] 2020―Nov―12 Camostat Mesylate against SARS-CoV-2 and COVID-19 - Rationale, Dosing and Safety Peter Breining, Anne Lier Frølund, Jesper Falkesgaard Højen, Jesper Damsgaard Gunst, Nina B. Staerke, Eva Saedder, et al. (+5)
13 [GO] 2020―Oct―25 COVID-19: A Case for Inhibiting NLRP3 Inflammasome, Suppression of Inflammation with Curcumin? Ali Saeedi-Boroujeni, Mohammad-Reza Mahmoudian-Sani, Mohammad Bahadoram, Arash Alghasi
14 [GO] 2020―Sep―21 COVID-19 clinical trials: ethical and scientific consequences of the RECOVERY trial results Rafael Dal-Ré, Raphaël Porcher, Christian Gluud
 [1] 

14 Results       Page 1



[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec